Similar articles

• Inotropic agents in the treatment of cardiogenic shock.

  Bourdarias JP, Dubourg O, Gueret P, Ferrier A, Bardet J. Bourdarias JP, et al. Pharmacol Ther. 1983;22(1):53-79. doi: 10.1016/0163-7258(83)90052-9. Pharmacol Ther. 1983. PMID: 6361798 Review. No abstract available.
• Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.

  El Mokhtari NE, Arlt A, Meissner A, Lins M. El Mokhtari NE, et al. Eur J Med Res. 2007 Nov 5;12(11):563-7. Eur J Med Res. 2007. PMID: 18024265
• Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.

  Mueller H, Ayres SM, Giannelli S Jr, Conklin EF, Mazzara JT, Grace WJ. Mueller H, et al. Circulation. 1972 Feb;45(2):335-51. doi: 10.1161/01.cir.45.2.335. Circulation. 1972. PMID: 5009478 No abstract available.
• Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.

  Goldberg LI, Hsieh YY, Resnekov L. Goldberg LI, et al. Prog Cardiovasc Dis. 1977 Jan-Feb;19(4):327-40. doi: 10.1016/0033-0620(77)90007-x. Prog Cardiovasc Dis. 1977. PMID: 12536 Review. No abstract available.
• [Comparative studies on the hemodynamic effects of dobutamine, dopamine, and isoproterenol in dogs in experimental shock (author's transl)].

  Matsumura S, Morishige E, Uno O, Ueda M. Matsumura S, et al. Nihon Yakurigaku Zasshi. 1980 Mar;76(2):131-41. Nihon Yakurigaku Zasshi. 1980. PMID: 7399367 Japanese.